摘要 |
The use of a compound of formula (I) in the manufacture of a medicament for the treatment, in a warm-blooded animal, of disorders mediated by the neuropeptide Y5 receptor wherein R1, R2, A, B, R3 and R4 are as defined within or a pharmaceutically acceptable salt, prodrug or solvate thereof, is described. Pharmaceutical compositions, methods and processes for preparation of compounds of formula (I) are also described.
|
申请人 |
ASTRAZENECA UK LIMITED;BLOCK, MICHAEL, HOWARD;DONALD, SAMUEL, CRAIG;FOOTE, KEVIN;SCHOFIELD, PAUL;MARSHAM, PETER, ROBERT |
发明人 |
BLOCK, MICHAEL, HOWARD;DONALD, SAMUEL, CRAIG;FOOTE, KEVIN;SCHOFIELD, PAUL;MARSHAM, PETER, ROBERT |